Functional Roles of Long Non-coding RNAs on Stem Cell-related Pathways in Glioblastoma

Arya Moftakhar, S. E. Khoshnam, Maryam Farzaneh, Mahrokh Abouali Gale Dari
{"title":"Functional Roles of Long Non-coding RNAs on Stem Cell-related Pathways in Glioblastoma","authors":"Arya Moftakhar, S. E. Khoshnam, Maryam Farzaneh, Mahrokh Abouali Gale Dari","doi":"10.2174/0115743624311471240703071345","DOIUrl":null,"url":null,"abstract":"\n\nLong non-coding RNAs (lncRNAs), characterized by their length exceeding 200 nucleotides\nand lack of protein-coding capacity, are intricately associated with a wide array of cellular\nprocesses, encompassing cell invasion, differentiation, proliferation, migration, apoptosis,\nand regeneration. Perturbations in lncRNA expression have been observed in numerous diseases\nand have emerged as pivotal players in the pathogenesis of diverse tumor types. Glioblastoma, a\nhighly malignant primary tumor of the central nervous system (CNS), remains a formidable\nchallenge even with the advent of novel therapeutic interventions, as primary glioblastomas invariably\nexhibit therapy resistance and aggressive behavior. Glioblastomas can arise from progenitor\ncells or neuroglial stem cells, revealing profound cellular heterogeneity, notably in the\nform of glioblastoma stem cells (GSCs) possessing stem-like properties. Glioblastomas comprise\nneural precursors that harbor essential characteristics of neural stem cells (NSCs). Several\nsignaling pathways have been implicated in the regulation of self-renewal in both cancer cells\nand stem cells. In addition to their involvement in therapy resistance and survival of glioblastoma,\nlncRNAs are implicated in the modulation of GSC behaviors through diverse pathways and\nthe intricate regulation of various genes and proteins. This review aims to comprehensively discuss\nthe interplay between lncRNAs, their associated pathways, and GSCs, shedding light on\ntheir potential implications in glioblastoma.\n","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"83 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Signal Transduction Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115743624311471240703071345","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Long non-coding RNAs (lncRNAs), characterized by their length exceeding 200 nucleotides and lack of protein-coding capacity, are intricately associated with a wide array of cellular processes, encompassing cell invasion, differentiation, proliferation, migration, apoptosis, and regeneration. Perturbations in lncRNA expression have been observed in numerous diseases and have emerged as pivotal players in the pathogenesis of diverse tumor types. Glioblastoma, a highly malignant primary tumor of the central nervous system (CNS), remains a formidable challenge even with the advent of novel therapeutic interventions, as primary glioblastomas invariably exhibit therapy resistance and aggressive behavior. Glioblastomas can arise from progenitor cells or neuroglial stem cells, revealing profound cellular heterogeneity, notably in the form of glioblastoma stem cells (GSCs) possessing stem-like properties. Glioblastomas comprise neural precursors that harbor essential characteristics of neural stem cells (NSCs). Several signaling pathways have been implicated in the regulation of self-renewal in both cancer cells and stem cells. In addition to their involvement in therapy resistance and survival of glioblastoma, lncRNAs are implicated in the modulation of GSC behaviors through diverse pathways and the intricate regulation of various genes and proteins. This review aims to comprehensively discuss the interplay between lncRNAs, their associated pathways, and GSCs, shedding light on their potential implications in glioblastoma.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
长非编码 RNA 在胶质母细胞瘤干细胞相关通路中的功能作用
长非编码 RNA(lncRNA)的特点是其长度超过 200 个核苷酸且缺乏编码蛋白质的能力,它们与一系列细胞过程密切相关,包括细胞侵袭、分化、增殖、迁移、凋亡和再生。在许多疾病中都观察到了 lncRNA 表达的紊乱,并已成为多种肿瘤发病机制中的关键角色。胶质母细胞瘤是中枢神经系统(CNS)的一种高度恶性的原发性肿瘤,即使在新型治疗干预措施出现之后,它仍然是一个巨大的挑战,因为原发性胶质母细胞瘤总是表现出耐药性和侵袭性。胶质母细胞瘤可产生于祖细胞或神经胶质干细胞,显示出深刻的细胞异质性,特别是胶质母细胞瘤干细胞(GSCs)具有干样特性。胶质母细胞瘤包括神经干细胞(NSC)的基本特征的神经前体。在癌细胞和干细胞自我更新的调控过程中,存在着多种信号通路。除了参与胶质母细胞瘤的耐药和存活外,lncRNA还通过不同的途径和对各种基因和蛋白的复杂调控参与了对GSC行为的调节。本综述旨在全面探讨lncRNAs及其相关通路与GSCs之间的相互作用,揭示它们在胶质母细胞瘤中的潜在影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
18
审稿时长
>12 weeks
期刊介绍: In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders. The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.
期刊最新文献
Functional Roles of Long Non-coding RNAs on Stem Cell-related Pathways in Glioblastoma Antidiabetic Advancements In Silico: Pioneering Novel Heterocyclic Derivatives through Computational Design Exploring Squalene's Impact on Epidermal Thickening and Collagen Production: Molecular Docking Insights Atopic Dermatitis and Abrocitinib: Unraveling the Therapeutic Potential Atrial Natriuretic Peptide as a Biomarker and Therapeutic Target in Cancer: A Focus on Colorectal Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1